Biolife Solutions 

$26.54
21
+$0.44+1.69% Today

Statistics

Day High
27.7
Day Low
26.26
52W High
28.79
52W Low
18.15
Volume
67,505,039
Avg. Volume
-
Mkt Cap
1.28B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.33
-0.21
-0.09
0.03
Expected EPS
0.025
Actual EPS
N/A

Financials

-4.5%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
204.38MRevenue
-9.19MNet Income

Analyst Ratings

32.00Average Price Target
The highest estimate is 32.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BLFS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GraniteShares YieldBOOST CRCL
CRY
Mkt Cap0
CryoLife manufactures and distributes cryogenic and other preservation services, directly competing with BioLife's biopreservation media products.
Brown & Brown
BRO
Mkt Cap20.33B
Brooks Automation provides automated cold storage solutions and services, competing in the biostorage sector with BioLife.
Thermo Fisher Scientific
TMO
Mkt Cap174.42B
Thermo Fisher Scientific offers a broad range of products for the bioprocessing and preservation sectors, overlapping with BioLife's offerings.
Becton Dickinson
BDX
Mkt Cap40.3B
Becton, Dickinson and Company offers products and services in the biosciences field, including cell therapy solutions that compete with BioLife's products.
Danaher
DHR
Mkt Cap127.47B
Danaher Corporation's life sciences division offers products and services that compete in the bioprocessing and preservation space.
Qiagen NV
QGEN
Mkt Cap7.64B
Qiagen provides sample and assay technologies for molecular diagnostics, applying preservation technologies that can compete with BioLife's solutions.
Illumina
ILMN
Mkt Cap24.35B
Illumina offers genomic sequencing solutions that require high-quality preservation of samples, indirectly competing with BioLife's preservation media.
Pacific Biosciences of California
PACB
Mkt Cap406.89M
Pacific Biosciences provides genomic analysis systems that also necessitate high-quality sample preservation, competing in the broader biopreservation market.
Agenus
AGEN
Mkt Cap137.42M
Agenus is involved in the discovery and development of immunotherapies, which requires the preservation of biological samples, indirectly competing with BioLife.
Novavax
NVAX
Mkt Cap1.46B
Novavax, a vaccine development company, requires stringent biopreservation for its products, making it a competitor in the biopreservation market.

About

BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.
Show more...
CEO
Mr. Roderick de Greef
Employees
159
Country
United States
ISIN
US09062W2044

Listings

0 Comments

Share your thoughts

FAQ

What is Biolife Solutions stock price today?
The current price of BLFS is $26.54 USD — it has increased by +1.69% in the past 24 hours. Watch Biolife Solutions stock price performance more closely on the chart.
What is Biolife Solutions stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Biolife Solutions stocks are traded under the ticker BLFS.
Is Biolife Solutions stock price growing?
BLFS stock has risen by +1.69% compared to the previous week, the month change is a +27.84% rise, over the last year Biolife Solutions has showed a +20.47% increase.
What is Biolife Solutions market cap?
Today Biolife Solutions has the market capitalization of 1.28B
When is the next Biolife Solutions earnings date?
Biolife Solutions is going to release the next earnings report on August 06, 2026.
What were Biolife Solutions earnings last quarter?
BLFS earnings for the last quarter are 0.02 USD per share, whereas the estimation was 0.02 USD resulting in a +20% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Biolife Solutions revenue for the last year?
Biolife Solutions revenue for the last year amounts to 204.38M USD.
What is Biolife Solutions net income for the last year?
BLFS net income for the last year is -9.19M USD.
How many employees does Biolife Solutions have?
As of June 15, 2026, the company has 159 employees.
In which sector is Biolife Solutions located?
Biolife Solutions operates in the Health & Wellness sector.
When did Biolife Solutions complete a stock split?
The last stock split for Biolife Solutions was on January 29, 2014 with a ratio of 1:14.
Where is Biolife Solutions headquartered?
Biolife Solutions is headquartered in Bothell, United States.